Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes
Marc S. Sabatine(Brigham and Women's Hospital), Eugene Braunwald(Brigham and Women's Hospital), Robert P. Giugliano(Brigham and Women's Hospital), David A. Morrow(Brigham and Women's Hospital), Sabina A. Murphy(Brigham and Women's Hospital), Carolyn H. McCabe(Brigham and Women's Hospital), C. Michael Gibson, Paul Burton(Janssen (United States))
Cited by 750
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.1k